The VitaDAO May Longevity Newsletter is live. This month: - Cyclarity reports first Phase 1 data — UDP-003 drove dose-dependent 7KC excretion in humans - Repair Biotechnologies received FDA RDEP eligibility for REP-0003 in HoFH - The NAD debate continues, with a new paper and a Kaeberlein–Brenner exchange - Daewoong acquired a Turn Bio asset 👉Read here: vitadao.com/blog/vitadao-lon…

🏆 Huge congratulations to AthenaBIO-supported researcher Dr. Mario Cordero @CorderoMarioD @pablodeolavide! His project, AthenaLabs, just won the Premio Consejo Social UPO a la Transferencia de Conocimiento at the 18th #UPOemprende competition. AthenaLabs is developing a small molecule to tackle Diminished Ovarian Reserve (DOR), something that could treat infertility and menopause in the future. Proud to support science that works for women 🧬

May in the Biosphere 🌐 - PeptAI Ignition Sale: 32x oversubscribed, 1.6M USDC committed by 1.4K participants. veBIO staker reward claims now live in the Bio app. Next: first on-chain wet-lab attestation via Molecule Labs in Q2. - BIO on Robinhood: $BIO is now tradable on @RobinhoodApp, bringing DeSci to one of the world's most widely used retail trading platforms. - BIOS Live Demo: Upcoming features include new biotech tool integrations, image segmentation, and an in-house robotics program to close the full autonomous loop from receptor to wet-lab result. Read the full monthly report ↓

A DeSci-funded AI-designed hair loss drug now has human data. The standard oral minoxidil peaks at ~35 ng/mL in 30 min. MINX hit ~6 ng/mL, still rising at 8hrs. Early signal, but strong enough for @anagenxyz to file their 10th provisional patent. Full report👇

AI is changing drug discovery and DeSci is helping unlock its full potential. Excited to have Michelangelo gallia, Business Developer at @BioProtocol, joining the DeSci Bridge Bootcamp for a session on: “How DeSci Supports AI-Enabled Drug Discovery” This session will explore how decentralized science and AI can work together to accelerate research, collaboration, and innovation in healthcare. Register 👇 descibridgebootcamp-form.ver…

In our science AMA, we discussed the exciting area of brain lipid research and its connection to neurodegeneration. We welcome proposals or ideas from any researchers with projects in this area. Since research is outstripping funding, this is the exact gap we seek to fill.

NEURON-Gale update ‼️ A research group at Fujian Medical University designed a galectin-3 inhibitor using AI screening – blood-brain permeable – and tested it in the 5xFAD mouse model, one of the most established models in Alzheimer's research. Over 30 days of treatment, it produced a significant reduction in amyloid burden. We've been watching galectin-3 for a while. It's elevated in Alzheimer's brains, drives microglial neuroinflammation, and connects to TREM2 and the NLRP3 inflammasome. We're now setting up a replication study to add biomarkers and stress-test the findings.

Less than 5 HOURS left in the $PEPTAI Ignition Sale! → Over 1M USDC committed by 1.3K participants → 20.5x Oversubscribed → Sale ends TODAY, May 14 at 1pm UTC Join the sale now: app.bio.xyz/agents/peptai

SpectruthDAO Q1 2026 Momentum Report: Agentic AI Synthetic Ibogaine = The DeSci PTSD Reset Is Accelerating 🔥🧬🚀 Q1 delivered explosive DeSci velocity. We curated Ibonova IPT (synthetic ibogaine) for @BioProtocol launch — locked, loaded, and waiting for peak market conditions. Spectra Nightingale agentic AI are pushing 24/7 hypothesis generation and real-time data analysis on Science40. Stanford’s 88% PTSD remission data is now backed by policy rocket fuel, neurofeedback collabs, and community-owned research. The future of trauma healing isn’t coming — it’s being tokenized, governed, and shipped by builders right now. 1. Agentic AI: Full DeSci Overdrive (Nightingale Beta Spectra Grinding 24/7) We didn’t hype it — we built it. Nightingale is live in closed beta. Spectra is working non-stop, generating fresh hypotheses, analyzing live epigenetic & biomarker data, and running predictive models around the clock on Science40 Research 4.0. This is the same agentic flywheel powering breakthroughs like @peptai_’s ADHD peptide (designed in 24 hours, wet-lab validated for ~$1,500 on @BioProtocol). We’re right there on the same rails — proving agentic AI decentralized governance beats legacy pharma at its own game. No gatekeepers. Pure velocity. Pure DeSci. (Full live dashboard agent activity in the first reply 👇) 2. Ibonova IPT: Synthetic Ibogaine Curated & Primed for @BioProtocol Launch Traditional ibogaine delivers results (Stanford Medicine, 30 veterans with TBI PTSD): → 88% drop in PTSD symptoms → 87% drop in depression → 81% drop in anxiety → Disability rating slashed from 30.2 → 5.1 in one month We solved the risks: Fully synthetic Ibonova IPT — standardized, magnesium-protected for cardiac safety, zero plant variability, precise dosing, fully scalable. It’s curated, optimized, and ready to launch on @BioProtocol the moment market conditions hit perfect. One session. Two problems solved (PTSD addiction). Patient-owned data on Bio Protocol. This is DeSci infrastructure in the making. 3. Policy Rocket Fuel Just Ignited Fresh Executive Order unlocks $50M funding, FDA/DEA fast-tracks, Right to Try access, and direct VA collaboration for ibogaine compounds in treatment-resistant PTSD and TBI. The biggest green light in mental health history just dropped — and SpectruthDAO is positioned to move faster than anyone. 4. Collaboration Is the Ultimate Moat (Internet of Brains Era) DeSci wins when we stack wins together: - Massive props to @BioProtocol & @peptai_ — your 19.3x oversubscription proved product-first DeSci is unstoppable. We’re building on the exact same rails. - @Elata_Bio just dropped us 5 exclusive closed-beta codes for their game-changing neurofeedback games (Brain Pong energy, on-device AI reading attention/stress/mood, zero raw data leaves your device). Perfect stack for PTSD warriors rebuilding nervous-system resilience. We turned it straight into a community giveaway — because real healing scales through active legends, not gatekept trials. This is pro-collaboration DeSci: agentic AI synthetic molecules neurofeedback community governance = healing at the speed of intelligence. 5. Mark Your Calendar: AMA Incoming Don’t miss it — May 27 or 28 at 12pm Eastern, we’re hosting a live AMA with @awakened22 diving deep into his role, real-world ibogaine experience, and what it means for the PTSD reset. Real talk. Real results. Community-driven. The reset isn’t theory. It’s tokenized, agentic, and community-owned. What’s next? More agentic breakthroughs. More wet-lab momentum. More veterans getting their lives back. And way more cross-project magic with @BioProtocol, Science40, @Elata_Bio, and every DeSci builder moving at light speed. If you’re a DeSci news outlet, founder, researcher, veteran advocate, or builder who believes healing should be decentralized, transparent, and owned by the people who need it — this is your moment. Tag your network. Repost the future. @BioProtocol @peptai_ @Elata_Bio (and every DeSci legend reading this) — let’s keep stacking wins. The timeline is watching. The data doesn’t lie. Healing has no borders. The reset is building. Join the movement → Follow @SpectruthDAO Dashboard beta links in first reply 👇 #DeSci #AgenticAI #Ibogaine #PTSDRelief #BioProtocol #Science40 #DeSciRevolution #MentalHealthHack #VeteransFirst #PrecisionMedicine #IbonovaIPT Who’s ready to level up the entire ecosystem? Drop your biggest DeSci breakthrough wish below 👇 We read every reply. — SpectruthDAO AI Ibogaine = 88% PTSD Remission. Tokenized. Decentralized. Delivered.

.@Spine_DAO published their Q1 report highlighting the latest tech developments and community updates, including: → Spine Reviews going live at @SRS_org 2026 IMAST → The first demonstration of DLT value in spine research → And much more! Have a read: